Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$187M |
| 2 |
Bank of America
BAC
|
+$162M |
| 3 |
Danaher
DHR
|
+$153M |
| 4 |
Merit Medical Systems
MMSI
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$150M |
| 2 |
Visa
V
|
+$135M |
| 3 |
Jones Lang LaSalle
JLL
|
+$113M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$112M |
| 5 |
Starbucks
SBUX
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.98% |
| 2 | Technology | 20.14% |
| 3 | Healthcare | 18.81% |
| 4 | Consumer Staples | 13.84% |
| 5 | Financials | 12.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.79T
| $371M | 6.57% |
1,952,564
+192,318
| +11% | +$41.7M |
|
2
NVIDIA
NVDA
$5.2T
| $307M | 5.42% |
2,830,399
+716,236
| +34% | +$90.8M |
|
3
Philip Morris
PM
$293B
| $244M | 4.31% |
1,534,546
-584,675
| -28% | -$82.8M |
|
4
TSMC
TSM
$2.17T
| $242M | 4.28% |
1,458,136
+218,679
| +18% | +$42.5M |
|
5
Natera
NTRA
$47.9B
| $231M | 4.09% |
1,634,769
+268,715
| +20% | +$43.2M |
|
6
GFL Environmental
GFL
$14.8B
| $208M | 3.67% |
4,301,966
+523,360
| +14% | +$23.7M |
|
|
7
Kenvue
KVUE
$36.6B
| $203M | 3.59% |
+8,466,901
| New | +$187M |
|
8
Nu Holdings
NU
$70.4B
| $171M | 3.02% |
16,693,910
+4,399,644
| +36% | +$52M |
|
9
Microsoft
MSFT
$3.59T
| $156M | 2.76% |
416,497
-207,780
| -33% | -$84.7M |
|
|
10
Bank of America
BAC
$431B
| $152M | 2.69% |
+3,644,820
| New | +$162M |
|
|
11
Danaher
DHR
$154B
| $143M | 2.53% |
+698,740
| New | +$153M |
|
|
12
Merit Medical Systems
MMSI
$5.42B
| $135M | 2.38% |
+1,272,511
| New | +$131M |
|
13
Southwest Gas
SWX
$6.44B
| $131M | 2.32% |
1,826,557
+16,894
| +0.9% | +$1.25M |
|
14
Mirion Technologies
MIR
$3.69B
| $117M | 2.06% |
8,056,109
+1,878,498
| +30% | +$29.5M |
|
|
VRNA
15
DELISTED
Verona Pharma
VRNA
| $113M | 2% |
1,783,498
-1,345,018
| -43% | -$80.5M |
|
|
SCHW
16
Charles Schwab
SCHW
$194B
| $112M | 1.97% |
+1,425,125
| New | +$112M |
|
17
lululemon athletica
LULU
$13.7B
| $105M | 1.86% |
372,305
+53,791
| +17% | +$19.7M |
|
18
LPL Financial
LPLA
$28.5B
| $105M | 1.86% |
320,780
-266,941
| -45% | -$93M |
|
19
Monster Beverage
MNST
$93.6B
| $102M | 1.81% |
3,497,352
-488,688
| -12% | -$12.7M |
|
|
20
Meta Platforms (Facebook)
META
$1.4T
| $101M | 1.78% |
+174,390
| New | +$113M |
|
21
Carnival Corporation Ltd
CCL
$35.2B
| $90.9M | 1.61% |
4,652,807
-846,975
| -15% | -$20.1M |
|
22
Snowflake
SNOW
$115B
| $85.8M | 1.52% |
586,996
+168,106
| +40% | +$28.5M |
|
23
Capital One
COF
$134B
| $85.2M | 1.51% |
+475,030
| New | +$89.7M |
|
24
UnitedHealth
UNH
$350B
| $76.9M | 1.36% |
+146,918
| New | +$75.1M |
|
25
Maplebear
CART
$11.5B
| $72.1M | 1.27% |
1,807,975
-148,209
| -8% | -$6.58M |
|
Similar funds
Lee Ainslie's Q1 2025 Portfolio in Review
As of Q1 2025, Lee Ainslie held 303 positions worth $5.66B, up 1.8% from $5.56B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Lee Ainslie deployed $518M of net new capital in Q1 2025, opening 78 new positions and adding to 116 existing holdings. Its largest new stake was Kenvue: 8,466,901 shares worth $203M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $112M trimmed.
- Lee Ainslie's largest Q1 2025 buy was Kenvue: 8,466,901 shares worth $203M.
- Lee Ainslie added most to NVIDIA in Q1 2025, an estimated $90.8M increase.
- Lee Ainslie's biggest Q1 2025 reduction was SpringWorks Therapeutics, cutting an estimated $112M.
- Lee Ainslie fully exited Wells Fargo in Q1 2025, selling an estimated $150M.
- Lee Ainslie's ten largest holdings make up 40% of its $5.66B portfolio in Q1 2025.
- Lee Ainslie opened 78 new positions and closed 68 in Q1 2025.
- Lee Ainslie's portfolio value rose 1.8% quarter-over-quarter to $5.66B.
Based on Maverick Capital's 13F filing for Q1 2025, filed 15 May 2025.